Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women’s

Y Mossavar-Rahmani, V Kamensky, JAE Manson, B Silver, SR Rapp, B Haring…

https://doi.org/10.1161/STROKEAHA.118.023100Stroke. 2019;50:555–562

Published: 14 Feb 2019

Background and Purpose

We examine the association between self-reported consumption of artificially sweetened beverages (ASB) and stroke and its subtypes, coronary heart disease, and all-cause mortality in a cohort of postmenopausal US women.

Methods

The analytic cohort included 81 714 women from the Women’s Health Initiative Observational Study, a multicenter longitudinal study of the health of 93 676 postmenopausal women of ages 50 to 79 years at baseline who enrolled in 1993 to 1998. This prospective study had a mean follow-up time of 11.9 years (SD of 5.3 years.) Participants who completed a follow-up visit 3 years after baseline were included in the study.

Results

Most participants (64.1%) were infrequent consumers (never or <1/week) of ASB, with only 5.1% consuming ≥2 ASBs/day. In multivariate analyses, those consuming the highest level of ASB compared to never or rarely (<1/wk) had significantly greater likelihood of all end points (except hemorrhagic stroke), after controlling for multiple covariates. Adjusted models indicated that hazard ratios and 95% confidence intervals were 1.23 (1.02–1.47) for all stroke; 1.31 (1.06–1.63) for ischemic stroke; 1.29 (1.11–1.51) for coronary heart disease; and 1.16 (1.07–1.26) for all-cause mortality. In women with no prior history of cardiovascular disease or diabetes mellitus, high consumption of ASB was associated with more than a 2-fold increased risk of small artery occlusion ischemic stroke hazard ratio =2.44 (95% confidence interval, 1.47–4.04.) High consumption of ASBs was associated with significantly increased risk of ischemic stroke in women with body mass index ≥30; hazard ratio =2.03 (95% confidence interval, 1.38–2.98).

Conclusions

Higher intake of ASB was associated with increased risk of stroke, particularly small artery occlusion subtype, coronary heart disease, and all-cause mortality. Although requiring replication, these new findings add to the potentially harmful association of consuming high quantities of ASB with these health outcomes. Read more

Executive Chef Giuseppe Urbano

Executive Chef Giuseppe Urbano is a Certified Executive Chef, clinical culinary innovator, and the founder of Meals For Longevity™ (MFL). Operating out of the Sarasota, Florida area, Chef Giuseppe has dedicated his career to bridging the gap between gourmet culinary arts and evidence-based clinical nutrition.

He is the architect of the MFL Program Framework™ and the proprietary Dual-Track Nutritional System, which allows clients to seamlessly navigate between the authentic Modern Mediterranean Path and a high-protein New American 2025 (DGA) Upgrade, known as The Metabolic Switch™.

Chef Giuseppe’s protocols are meticulously engineered to combat cardio-metabolic diseases sustainably. His culinary frameworks are strictly aligned with the highest global nutritional standards, including the MedDiet 4.0 updates, LARN 2014/2024 guidelines, and the 2025 Dietary Guidelines for Americans. Through his 28-Day Transformation program and clinical recipe development, he empowers individuals to achieve sustainable weight management, cellular health, and long-term metabolic vitality without sacrificing the joy of eating.

https://www.chefgiuseppeurbano.com
Previous
Previous

A Mediterranean diet and low-fat vegan diet to improve body weight and cardiometabolic risk factors: a cross-over trial